• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma.

作者信息

Nair Remya, Subramaniam Vimal, Barwick Benjamin G, Gupta Vikas A, Matulis Shannon M, Lonial Sagar, Boise Lawrence H, Nooka Ajay K, Muthumalaiappan Kuzhali, Shanmugam Mala

机构信息

Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA.

Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA; Burn and Shock Trauma Research Institute, Loyola University Chicago, Chicago, Illinois.

出版信息

Haematologica. 2022 Sep 1;107(9):2226-2231. doi: 10.3324/haematol.2022.280907.

DOI:10.3324/haematol.2022.280907
PMID:35511673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425311/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/4b95e9935155/1072226.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/985592ace516/1072226.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/b33775949dd7/1072226.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/4b95e9935155/1072226.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/985592ace516/1072226.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/b33775949dd7/1072226.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a019/9425311/4b95e9935155/1072226.fig3.jpg

相似文献

1
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma.β肾上腺素能信号传导调节多发性骨髓瘤中造血干细胞和祖细胞的定向分化及治疗敏感性。
Haematologica. 2022 Sep 1;107(9):2226-2231. doi: 10.3324/haematol.2022.280907.
2
Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: A pilot study.地昔帕明通过刺激肾上腺素能活性增强多发性骨髓瘤患者造血干细胞和祖细胞动员作用及其与 G-CSF 的协同作用：一项初步研究。
Am J Hematol. 2017 Oct;92(10):1047-1051. doi: 10.1002/ajh.24843. Epub 2017 Jul 29.
3
Marker gene transfer into leukapheresis preparations containing hematopoietic progenitor cells: application in high-dose therapy rescued by reinfusion of peripheral blood hematopoietic progenitors in patients with multiple myeloma.将标记基因导入含有造血祖细胞的白细胞单采制品：在多发性骨髓瘤患者高剂量治疗中的应用，该治疗通过回输外周血造血祖细胞得以挽救。
J Mol Med (Berl). 1995 Apr;73(4):197-203. doi: 10.1007/BF00188140.
4
Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.环磷酰胺和粒细胞巨噬细胞集落刺激因子治疗后多发性骨髓瘤中骨髓瘤细胞和正常造血干细胞的差异动员
Blood. 1996 Jan 15;87(2):805-11.
5
Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era.多发性骨髓瘤自体干细胞移植中造血祖细胞动员的当代策略。
Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):200-205. doi: 10.1016/j.clml.2018.12.010. Epub 2018 Dec 20.
6
Letter to the Editor Regarding "Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients".致编辑的信：关于“骨髓瘤患者为未来挽救性自体移植或干细胞强化而储存的造血祖细胞的利用及成本影响”
Transplant Cell Ther. 2021 Mar;27(3):199-200. doi: 10.1016/j.jtct.2020.11.010. Epub 2020 Dec 14.
7
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.长春瑞滨联合粒细胞集落刺激因子对多发性骨髓瘤患者CD34+造血祖细胞动员的疗效
Biol Blood Marrow Transplant. 2015 Jan;21(1):74-80. doi: 10.1016/j.bbmt.2014.09.020. Epub 2014 Sep 30.
8
Hematopoietic progenitor cell mobilization using low-dose cyclophosphamide and granulocyte colony-stimulating factor for multiple myeloma.使用低剂量环磷酰胺和粒细胞集落刺激因子进行造血祖细胞动员治疗多发性骨髓瘤。
J Clin Apher. 2013 Oct;28(5):368-73. doi: 10.1002/jca.21283. Epub 2013 Jun 27.
9
Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.
Nouv Rev Fr Hematol (1978). 1995;37(6):381-3.
10
[Myeloma stem/progenitor cells as new targets for therapy of multiple myeloma--review].[骨髓瘤干细胞/祖细胞作为多发性骨髓瘤治疗的新靶点——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1459-64.

引用本文的文献

1
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol.GPC-100，一种新型 CXCR4 拮抗剂，与普萘洛尔联合使用可改善体内造血细胞动员。
PLoS One. 2023 Oct 25;18(10):e0287863. doi: 10.1371/journal.pone.0287863. eCollection 2023.

本文引用的文献

1
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.多发性骨髓瘤由于骨髓微环境中 CCL3 水平升高而抑制红细胞生成并导致贫血。
Sci Rep. 2020 Nov 25;10(1):20508. doi: 10.1038/s41598-020-77450-y.
2
Transient Improvement in Erythropoiesis Is Achieved Via the Chaperone AHSP With Early Administration of Propranolol in Burn Patients.烧伤患者早期应用普萘洛尔通过伴侣蛋白 AHSP 实现红细胞生成的短暂改善。
J Burn Care Res. 2021 Mar 4;42(2):311-322. doi: 10.1093/jbcr/iraa150.
3
Autonomic nervous system control of multiple myeloma.
自主神经系统对多发性骨髓瘤的控制。
Blood Rev. 2021 Mar;46:100741. doi: 10.1016/j.blre.2020.100741. Epub 2020 Aug 11.
4
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.电子传递链活性是多发性骨髓瘤中 venetoclax 敏感性的预测因子和靶点。
Nat Commun. 2020 Mar 6;11(1):1228. doi: 10.1038/s41467-020-15051-z.
5
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.普萘洛尔抑制造血干细胞移植受者的分子风险标志物：一项2期随机对照生物标志物试验。
Blood Adv. 2020 Feb 11;4(3):467-476. doi: 10.1182/bloodadvances.2019000765.
6
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.多发性骨髓瘤免疫球蛋白 λ 易位预示预后不良。
Nat Commun. 2019 Apr 23;10(1):1911. doi: 10.1038/s41467-019-09555-6.
7
MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.MAFb 蛋白赋予多发性骨髓瘤对蛋白酶体抑制剂的固有耐药性。
BMC Cancer. 2018 Jul 6;18(1):724. doi: 10.1186/s12885-018-4602-4.
8
The bone-marrow niche in MDS and MGUS: implications for AML and MM.骨髓基质在 MDS 和 MGUS 中的作用：对 AML 和 MM 的影响。
Nat Rev Clin Oncol. 2018 Apr;15(4):219-233. doi: 10.1038/nrclinonc.2017.197. Epub 2018 Jan 9.
9
Myelo-erythroid commitment after burn injury is under β-adrenergic control via MafB regulation.烧伤后骨髓红系定向分化受β-肾上腺素能通过MafB调控。
Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C286-C301. doi: 10.1152/ajpcell.00139.2016. Epub 2016 Dec 28.
10
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.肿瘤学中药物的重新利用（ReDO）——普萘洛尔作为一种抗癌药物。
Ecancermedicalscience. 2016 Oct 12;10:680. doi: 10.3332/ecancer.2016.680. eCollection 2016.